Erwin H Ludwig is a notable inventor based in San Anselmo, California. He has made significant contributions to the field of genetics, particularly in the study of diacylglycerol acyltransferase (DGAT) genes. With a total of 2 patents, his work has implications for understanding conditions related to DGAT activity.

Latest Patents

Ludwig's latest patents focus on polymorphisms in a diacylglycerol acyltransferase gene and methods of use thereof. The first patent provides an isolated polynucleotide comprising a polymorphic nucleotide sequence from a DGAT gene, wherein at least one polymorphism is associated with a condition relating to DGAT activity. This invention also includes diagnostic assays for detecting the presence of a polymorphism in a nucleic acid sample, which is crucial for identifying a propensity to develop conditions associated with DGAT activity. Furthermore, it outlines treatment methods related to these findings.

Career Highlights

Erwin H Ludwig is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical diagnostics and treatment strategies.

Collaborations

Ludwig has collaborated with esteemed colleagues such as Robert V Farese, Jr. and Thomas L Innerarity, contributing to a rich environment of innovation and research.

Conclusion

Erwin H Ludwig's contributions to the understanding of diacylglycerol acyltransferase genes highlight his role as a significant inventor in the field of genetics. His patents pave the way for advancements in diagnostics and treatment methods related to DGAT activity.